Literature DB >> 16827823

Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial.

S Petrou1, J Trinder, P Brocklehurst, L Smith.   

Abstract

OBJECTIVES: To compare the cost-effectiveness of alternative management methods of first-trimester miscarriage.
DESIGN: Economic evaluation conducted alongside a large randomised controlled trial (the MIST trial).
SETTING: Early pregnancy assessment units of seven participating hospitals in southern England. SAMPLE: A total of 1200 women with a confirmed pregnancy of less than 13 weeks of gestation with a diagnosis of incomplete miscarriage or missed miscarriage.
METHODS: Random allocation to expectant management, medical management or surgical management. Collection of health service and broader resource use data, unit costs for each resource item and clinical outcomes. MAIN OUTCOME MEASURES: Costs (pounds, 2001-02 prices) to the health service, social services, women, carers and wider society during the first 8 weeks postrandomisation. Cost-effectiveness estimates, expressed in terms of incremental cost per gynaecological infection prevented; cost-effectiveness acceptability curves presented at alternative willingness-to-pay thresholds for preventing gynaecological infection.
RESULTS: There was no significant difference in the incidence of gynaecological infection between groups. The net societal cost per woman was estimated at 1086.20 pounds in the expectant group, 1410.40 pounds in the medical group and 1585.30 pounds in the surgical group. Expectant management had a 97.8% probability of being the most cost-effective management method at a willingness-to-pay threshold of 10,000 pounds for preventing one gynaecological infection, while medical management had a 2.2% probability of being the most cost-effective management method. Expectant management retained the highest probability of being the most cost-effective management method at all willingness-to-pay thresholds of less than 70,000 pounds for preventing one gynaecological infection.
CONCLUSIONS: Expectant and medical management of first-trimester miscarriage possess significant economic advantages over traditional surgical management.

Entities:  

Mesh:

Year:  2006        PMID: 16827823     DOI: 10.1111/j.1471-0528.2006.00998.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  15 in total

1.  A Comparative Study to Evaluate the Efficacy of Vaginal vs Oral Prostaglandin E1 Analogue (Misoprostol) in Management of First Trimester Missed Abortion.

Authors:  Sheeba Marwah; Supriya Gupta; Neera Parothi Batra; Vidhu Bhasin; Veena Sarna; Nirlep Kaur
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.

Authors:  Arri Coomarasamy; Hoda M Harb; Adam J Devall; Versha Cheed; Tracy E Roberts; Ilias Goranitis; Chidubem B Ogwulu; Helen M Williams; Ioannis D Gallos; Abey Eapen; Jane P Daniels; Amna Ahmed; Ruth Bender-Atik; Kalsang Bhatia; Cecilia Bottomley; Jane Brewin; Meenakshi Choudhary; Fiona Crosfill; Shilpa Deb; W Colin Duncan; Andrew Ewer; Kim Hinshaw; Thomas Holland; Feras Izzat; Jemma Johns; Mary-Ann Lumsden; Padma Manda; Jane E Norman; Natalie Nunes; Caroline E Overton; Kathiuska Kriedt; Siobhan Quenby; Sandhya Rao; Jackie Ross; Anupama Shahid; Martyn Underwood; Nirmala Vaithilingham; Linda Watkins; Catherine Wykes; Andrew W Horne; Davor Jurkovic; Lee J Middleton
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

3.  Treatment Decisions at the Time of Miscarriage Diagnosis.

Authors:  Courtney A Schreiber; Veronica Chavez; Paul G Whittaker; Sarah J Ratcliffe; Ebony Easley; Frances K Barg
Journal:  Obstet Gynecol       Date:  2016-12       Impact factor: 7.661

4.  A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss.

Authors:  Mary Rausch; Scott Lorch; Karine Chung; Margaret Frederick; Jun Zhang; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-21       Impact factor: 7.329

Review 5.  Expectant care versus surgical treatment for miscarriage.

Authors:  Kavita Nanda; Laureen M Lopez; David A Grimes; Alessandra Peloggia; Geeta Nanda
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 6.  Medical treatments for incomplete miscarriage (less than 24 weeks).

Authors:  James P Neilson; Gillian Ml Gyte; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  Medical treatments for incomplete miscarriage.

Authors:  Caron Kim; Sharmani Barnard; James P Neilson; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

8.  Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial.

Authors:  Lindsay F P Smith; Paul D Ewings; Catherine Quinlan
Journal:  BMJ       Date:  2009-10-08

9.  Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS).

Authors:  Wendy V Norman; Judith A Soon; Nanamma Maughn; Jennifer Dressler
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.